Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1-Reference-Cited by-同舟云学术

Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1

Published:2020-05-05 Issue:1 Volume:75 Page:173-185
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Miyamoto Masakazu¹²,Kuzuya Akira¹,Noda Yasuha²,Ueda Sakiho¹,Asada-Utsugi Megumi²,Ito Shinji³,Fukusumi Yoshiyasu⁴,Kawachi Hiroshi⁴,Takahashi Ryosuke¹,Kinoshita Ayae²

Affiliation:

1. Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

2. Department of Human Health Science, Graduate School of Medicine, Kyoto University, Kyoto, Japan

3. Medical Research Support Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan

4. Department of Cell Biology, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference38 articles.

1. Alzheimer disease: An update on pathobiology and treatment strategies;Long;Cell,2019

2. Alzheimer’s disease: Synapses gone cold;Koffie;Mol Neurodegener,2011

3. Alzheimer’s disease is a synaptic failure;Selkoe;Science,2002

4. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: Implications for sequence of pathological events in Alzheimer’s disease;Jack;Brain,2009

5. Synaptic amyloid-beta oligomers precede p-tau and differentiate high pathology control cases;Bilousova;Am J Pathol,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of UBE2N as a biomarker of Alzheimer's disease by combining WGCNA with machine learning algorithms;2024-02-08

2. Changes of tRNA-Derived Fragments by Alzheimer’s Disease in Cerebrospinal Fluid and Blood Serum;Journal of Alzheimer's Disease;2023-11-21

3. Acute inhibition of AMPA receptors by perampanel reduces amyloid β‐protein levels by suppressing β‐cleavage of APP in Alzheimer's disease models;The FASEB Journal;2023-10-18

4. Genetic architecture of hippocampus subfields volumes in Alzheimer’s disease;CNS Neuroscience & Therapeutics;2023-02-08

5. Research Progress in Synaptic Vesicle Membrane Protein 2B in the Glioma;Advances in Clinical Medicine;2023